{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:28:14Z","timestamp":1792621694771,"version":"4.5.0"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cca.2023.117592","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:38:39Z","timestamp":1697049519000},"page":"117592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The pentraxin family in autoimmune disease"],"prefix":"10.1016","volume":"551","author":[{"given":"Yongzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouzan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117592_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103236","article-title":"Autoimmune pre-disease","volume":"22","author":"Bieber","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2023.117592_b0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2023.117592_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103312","article-title":"Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders","volume":"22","author":"Konen","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2023.117592_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102956","article-title":"Involvement of trained immunity during autoimmune responses","volume":"137","author":"Mora","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2023.117592_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0051-2016","article-title":"Interplay between Myeloid Cells and Humoral Innate Immunity","volume":"4","author":"Jaillon","year":"2016","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.cca.2023.117592_b0030","doi-asserted-by":"crossref","unstructured":"T.H. Mogensen, Pathogen recognition and inflammatory signaling in innate immune defenses, Clin Microbiol Rev. 22 (2009) 240\u2013273, Table of Contents. https:\/\/doi.org\/10.1128\/CMR.00046-08.","DOI":"10.1128\/CMR.00046-08"},{"key":"10.1016\/j.cca.2023.117592_b0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2023.117592_b0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0050","article-title":"Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?","volume":"11","author":"Brilland","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/367338a0","article-title":"Structure of pentameric human serum amyloid P component","volume":"367","author":"Emsley","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117592_b0060","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1006\/jmbi.1999.2956","article-title":"C-reactive protein and SAP-like pentraxin are both present in Limulus polyphemus haemolymph: crystal structure of Limulus SAP","volume":"290","author":"Shrive","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cca.2023.117592_b0065","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3389\/fimmu.2020.01757","article-title":"The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0070","doi-asserted-by":"crossref","first-page":"1085525","DOI":"10.3389\/fimmu.2022.1085525","article-title":"Editorial: The complement system in autoimmunity","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0075","unstructured":"S.M. Nehring, A. Goyal, B.C. Patel, C Reactive Protein, in: StatPearls, StatPearls Publishing, Treasure Island (FL), 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441843\/ (accessed September 20, 2023)."},{"key":"10.1016\/j.cca.2023.117592_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","article-title":"The phenomenon of the acute phase response","volume":"389","author":"Kushner","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2023.117592_b0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/qjmed\/hcg134","article-title":"C-reactive protein and cardiovascular disease: new insights from an old molecule","volume":"96","author":"Hirschfield","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.cca.2023.117592_b0090","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.lpm.2007.11.011","article-title":"Systemic lupus erythematosus: news and therapeutic perspectives","volume":"37","author":"Sibilia","year":"2008","journal-title":"Presse Med."},{"key":"10.1016\/j.cca.2023.117592_b0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nsb0496-346","article-title":"Three dimensional structure of human C-reactive protein","volume":"3","author":"Shrive","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.cca.2023.117592_b0100","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1016\/S0021-9258(17)38881-6","article-title":"Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component","volume":"260","author":"Woo","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/IR:30:3:261","article-title":"C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity","volume":"30","author":"Du Clos","year":"2004","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2023.117592_b0110","first-page":"163","article-title":"C-Reactive Protein","volume":"24","author":"Mortensen","year":"2001","journal-title":"Inflammation, and Innate Immunity, IR."},{"key":"10.1016\/j.cca.2023.117592_b0115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.03.179","article-title":"SAP: structure, function, and its roles in immune-related diseases","volume":"187","author":"Xi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2023.117592_b0120","doi-asserted-by":"crossref","first-page":"10147","DOI":"10.1074\/jbc.M708535200","article-title":"Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization","volume":"283","author":"Inforzato","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b0125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/jmbi.1997.1271","article-title":"Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses","volume":"272","author":"Ashton","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cca.2023.117592_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.1998.8248","article-title":"Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein","volume":"244","author":"Li","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2023.117592_b0135","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bpj.2016.01.030","article-title":"Making Sense of Intrinsically Disordered Proteins","volume":"110","author":"Dyson","year":"2016","journal-title":"Biophys. J ."},{"key":"10.1016\/j.cca.2023.117592_b0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a Humoral Pattern Recognition Molecule, Innate Immunity, Tissue Repair, and Cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cca.2023.117592_b0145","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1074\/jbc.M109.044529","article-title":"Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations","volume":"285","author":"Okemefuna","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b0150","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.4049\/jimmunol.166.11.6735","article-title":"Serum Amyloid P Component Binds to Fc\u03b3 Receptors and Opsonizes Particles for Phagocytosis","volume":"166","author":"Bharadwaj","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/jaut.2002.0615","article-title":"Serum Amyloid P Component and C-Reactive Protein Opsonize Apoptotic Cells for Phagocytosis through Fc\u03b3 Receptors","volume":"19","author":"Mold","year":"2002","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2023.117592_b0160","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nature07468","article-title":"Structural recognition and functional activation of Fc\u03b3R by innate pentraxins","volume":"456","author":"Lu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117592_b0165","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3389\/fimmu.2018.02382","article-title":"The Pentraxins 1975\u20132018: Serendipity","volume":"9","author":"Pepys","year":"2018","journal-title":"Diagnostics and Drugs, Front Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0170","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2016-06-724351","article-title":"Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions","volume":"129","author":"Muczynski","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117592_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676702","article-title":"PTX3 Regulation of Inflammation, Hemostatic Response, Tissue Repair, and Resolution of Fibrosis Favors a Role in Limiting Idiopathic Pulmonary Fibrosis","volume":"12","author":"Doni","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102584","article-title":"Pentraxin 3: A promising therapeutic target for autoimmune diseases","volume":"19","author":"Wu","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2023.117592_b0185","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.150.5.1804","article-title":"TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins","volume":"150","author":"Lee","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0190","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/cns.13913","article-title":"PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma","volume":"28","author":"Zhang","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cca.2023.117592_b0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2015.11.002","article-title":"PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition","volume":"38","author":"Garlanda","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0200","first-page":"303","article-title":"Human retinal pigment epithelial cells express the long pentraxin PTX3","volume":"19","author":"Woo","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.cca.2023.117592_b0205","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1074\/mcp.M500143-MCP200","article-title":"Proteomic Analysis of Human Neutrophil Granules","volume":"4","author":"Lominadze","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cca.2023.117592_b0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2023.117592_b0215","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.200324390","article-title":"Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells","volume":"33","author":"Doni","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00441-010-1018-0","article-title":"Pentraxins in innate immunity: lessons from PTX3","volume":"343","author":"Deban","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cca.2023.117592_b0225","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","article-title":"The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis","volume":"10","author":"Porte","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2008.00719.x","article-title":"The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity","volume":"227","author":"Bottazzi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cca.2023.117592_b0235","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1189\/jlb.0905493","article-title":"Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-","volume":"79","author":"Doni","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2023.117592_b0240","article-title":"The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy","volume":"12","author":"Stravalaci","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2023.117592_b0245","doi-asserted-by":"crossref","unstructured":"K. Daigo, M. Nakakido, R. Ohashi, R. Fukuda, K. Matsubara, T. Minami, N. Yamaguchi, K. Inoue, S. Jiang, M. Naito, K. Tsumoto, T. Hamakubo, Protective effect of the long pentraxin PTX3 against histone-mediated endothelial cell cytotoxicity in sepsis, Sci Signal. 7 (2014) ra88. https:\/\/doi.org\/10.1126\/scisignal.2005522.","DOI":"10.1126\/scisignal.2005522"},{"key":"10.1016\/j.cca.2023.117592_b0250","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fimmu.2016.00344","article-title":"The Protective Effect against Extracellular Histones Afforded by Long-Pentraxin PTX3 as a Regulator of NETs","volume":"7","author":"Daigo","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0260","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1084\/jem.20150282","article-title":"The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells","volume":"213","author":"Chorny","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2023.117592_b0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117592_b0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(03)00233-4","article-title":"Fungal beta-glucans and mammalian immunity","volume":"19","author":"Brown","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2023.117592_b0275","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1182\/blood-2009-12-258376","article-title":"Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus","volume":"116","author":"Moalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117592_b0280","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1189\/jlb.0803371","article-title":"PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages","volume":"75","author":"Diniz","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2023.117592_b0285","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cca.2023.117592_b0290","doi-asserted-by":"crossref","first-page":"1802976","DOI":"10.1155\/2020\/1802976","article-title":"Soluble PTX3 of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Attenuates Hyperoxic Lung Injury by Activating Macrophage Polarization in Neonatal Rat Model","volume":"2020","author":"Kim","year":"2020","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.cca.2023.117592_b0295","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.7150\/jca.58698","article-title":"Pentraxin-3 inhibits milky spots metastasis of gastric cancer by inhibiting M2 macrophage polarization","volume":"12","author":"Cui","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.cca.2023.117592_b0300","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-022-04962-y","article-title":"Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32","volume":"13","author":"Yin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2023.117592_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113783","article-title":"Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role","volume":"156","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2023.117592_b0310","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/MMBR.00050-15","article-title":"The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host","volume":"79","author":"Stewart","year":"2015","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.cca.2023.117592_b0315","doi-asserted-by":"crossref","first-page":"17681","DOI":"10.1074\/jbc.M109.085639","article-title":"The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2","volume":"285","author":"Inforzato","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b0320","doi-asserted-by":"crossref","first-page":"30161","DOI":"10.1074\/jbc.M703738200","article-title":"PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion","volume":"282","author":"Scarchilli","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b0325","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.20141268","article-title":"An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode","volume":"212","author":"Doni","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2023.117592_b0330","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/ATVBAHA.111.243998","article-title":"Long pentraxin 3\/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis","volume":"32","author":"Leali","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2023.117592_b0335","first-page":"53","article-title":"Long pentraxin 3: A novel multifaceted player in cancer","volume":"2018","author":"Giacomini","year":"1869","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2023.117592_b0340","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1074\/jbc.M002254200","article-title":"Biochemical Interactions of the Neuronal Pentraxins","volume":"275","author":"Kirkpatrick","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b0345","doi-asserted-by":"crossref","first-page":"e006098","DOI":"10.1161\/JAHA.112.006098","article-title":"Genetic Deletion of NP1 Prevents Hypoxic-Ischemic Neuronal Death Via Reducing AMPA Receptor Synaptic Localization in Hippocampal Neurons","volume":"2","author":"Rahim","year":"2013","journal-title":"JAHA."},{"key":"10.1016\/j.cca.2023.117592_b0350","doi-asserted-by":"crossref","first-page":"eabb4853","DOI":"10.1126\/science.abb4853","article-title":"A synthetic synaptic organizer protein restores glutamatergic neuronal circuits","volume":"369","author":"Suzuki","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cca.2023.117592_b0355","doi-asserted-by":"crossref","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","article-title":"The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration","volume":"15","author":"Zhou","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cca.2023.117592_b0360","doi-asserted-by":"crossref","first-page":"e23798","DOI":"10.7554\/eLife.23798","article-title":"NPTX2 and cognitive dysfunction in Alzheimer\u2019s Disease","volume":"6","author":"Xiao","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.cca.2023.117592_b0365","first-page":"5055","article-title":"Evolution of the Pentraxin Family","volume":"184","author":"Martinez de la Torre","year":"2010","journal-title":"The New Entry PTX4, J.I."},{"key":"10.1016\/j.cca.2023.117592_b0370","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/rheumatology\/kep368","article-title":"Genetic background of systemic sclerosis: autoimmune genes take centre stage","volume":"49","author":"Allanore","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117592_b0375","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.autrev.2010.02.003","article-title":"Pathways: Strategies for susceptibility genes in SLE","volume":"9","author":"Kelley","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2023.117592_b0380","doi-asserted-by":"crossref","unstructured":"C. Muangchan, S. Harding, S. Khimdas, A. Bonner, Canadian Scleroderma Research group, M. Baron, J. Pope, Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group, Arthritis Care Res (Hoboken). 64 (2012) 1405\u20131414. https:\/\/doi.org\/10.1002\/acr.21716.","DOI":"10.1002\/acr.21716"},{"key":"10.1016\/j.cca.2023.117592_b0385","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/acr.21968","article-title":"Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Care Res (hoboken)."},{"key":"10.1016\/j.cca.2023.117592_b0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"Czirj\u00e1k","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 113","key":"10.1016\/j.cca.2023.117592_b0395","first-page":"126","article-title":"The role of inflammatory markers in assessment of disease activity in systemic sclerosis","volume":"36","author":"Ross","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0400","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/kew017","article-title":"Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients","volume":"55","author":"Cossu","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117592_b0405","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/1346-8138.14669","article-title":"Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study","volume":"45","author":"Sumida","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.cca.2023.117592_b0410","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13075-019-2057-x","article-title":"Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide","volume":"21","author":"Mitev","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2023.117592_b0415","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/art.22694","article-title":"Normal circulating serum amyloid P component concentration in systemic sclerosis","volume":"56","author":"Tennent","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0420","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3899\/jrheum.080343","article-title":"Increased serum pentraxin 3 in patients with systemic sclerosis","volume":"36","author":"Iwata","year":"2009","journal-title":"J. Rheumatol."},{"issue":"Suppl 106","key":"10.1016\/j.cca.2023.117592_b0425","first-page":"221","article-title":"Significance of pentraxin-3 in patients with juvenile scleroderma","volume":"35","author":"Adrovic","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0430","doi-asserted-by":"crossref","first-page":"e0130166","DOI":"10.1371\/journal.pone.0130166","article-title":"Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide","volume":"10","author":"Borghini","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117592_b0435","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2002","article-title":"A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients","volume":"8","author":"Giusti","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2023.117592_b0440","first-page":"S66","article-title":"Scleroderma fibroblasts constitutively express the long pentraxin PTX3","volume":"22","author":"Luchetti","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0445","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/art.27522","article-title":"Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12","volume":"62","author":"Margheri","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0450","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13075-015-0563-z","article-title":"Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis","volume":"17","author":"Kim","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2023.117592_b0455","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10067-016-3483-7","article-title":"Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis","volume":"36","author":"\u0130lgen","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"Suppl 113","key":"10.1016\/j.cca.2023.117592_b0460","first-page":"102","article-title":"Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function","volume":"36","author":"Kawashiri","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0465","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/eji.201545950","article-title":"Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease","volume":"46","author":"Ummenthum","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0470","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/medicina58050567","article-title":"Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview","volume":"58","author":"M\u2019Koma","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.cca.2023.117592_b0475","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.cca.2023.117592_b0480","doi-asserted-by":"crossref","unstructured":"M.H. Mosli, G. Zou, S.K. Garg, S.G. Feagan, J.K. MacDonald, N. Chande, W.J. Sandborn, B.G. Feagan, C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis, Am J Gastroenterol. 110 (2015) 802\u2013819; quiz 820. https:\/\/doi.org\/10.1038\/ajg.2015.120.","DOI":"10.1038\/ajg.2015.120"},{"key":"10.1016\/j.cca.2023.117592_b0485","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cca.2023.117592_b0490","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2023.117592_b0495","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MIB.0000000000000341","article-title":"Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission","volume":"21","author":"Falvey","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2023.117592_b0500","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ecco-jcc\/jjx124","article-title":"Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease","volume":"12","author":"Hosomi","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cca.2023.117592_b0505","first-page":"786","article-title":"Faecal Lactoferrin","volume":"10","author":"Langhorst","year":"2016","journal-title":"Calprotectin, PMN-Elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial, J Crohns Colitis."},{"key":"10.1016\/j.cca.2023.117592_b0510","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/MIB.0000000000000935","article-title":"Silent Crohn\u2019s Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation","volume":"22","author":"Bhattacharya","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2023.117592_b0515","doi-asserted-by":"crossref","first-page":"e0179266","DOI":"10.1371\/journal.pone.0179266","article-title":"Elevated C-reactive protein level during clinical remission can predict poor outcomes in patients with Crohn\u2019s disease","volume":"12","author":"Oh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117592_b0520","doi-asserted-by":"crossref","first-page":"16032","DOI":"10.1038\/cddiscovery.2016.32","article-title":"C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn\u2019s disease","volume":"2","author":"Iaculli","year":"2016","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cca.2023.117592_b0525","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00535-013-0807-0","article-title":"C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn\u2019s disease","volume":"49","author":"Hibi","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cca.2023.117592_b0530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10620-011-1955-9","article-title":"Outcome predictors for thiopurine maintenance therapy in patients with Crohn\u2019s disease","volume":"57","author":"Park","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cca.2023.117592_b0535","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2008.08.028","article-title":"Groupe D\u2019Etude Th\u00e9rapeutique Des Affections Inflammatoires Du Tube Digestif (GETAID), Azathioprine withdrawal in patients with Crohn\u2019s disease maintained on prolonged remission: a high risk of relapse","volume":"7","author":"Treton","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2023.117592_b0540","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"Travis","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cca.2023.117592_b0545","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2020.12.014","article-title":"Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC","volume":"514","author":"Wang","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117592_b0550","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/mmr.2015.3451","article-title":"Serum pentraxin 3 is a novel marker in Crohn\u2019s disease","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2023.117592_b0555","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1827.2011.02651.x","article-title":"Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis","volume":"61","author":"Savchenko","year":"2011","journal-title":"Pathol. Int."},{"key":"10.1016\/j.cca.2023.117592_b0560","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/ozhc85","article-title":"Systemic vasculitis: one year in review 2022","author":"La Rocca","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2013","key":"10.1016\/j.cca.2023.117592_b0565","first-page":"1","article-title":"revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0570","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2010.10.002","article-title":"Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging","volume":"155","author":"Jiang","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2023.117592_b0575","doi-asserted-by":"crossref","unstructured":"M. Webb, A. Chambers, A. AL-Nahhas, J.C. Mason, L. Maudlin, L. Rahman, J. Frank, The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis, Eur J Nucl Med Mol Imaging. 31 (2004) 627\u2013634. https:\/\/doi.org\/10.1007\/s00259-003-1429-1.","DOI":"10.1007\/s00259-003-1429-1"},{"key":"10.1016\/j.cca.2023.117592_b0580","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00259-004-1757-9","article-title":"The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease","volume":"32","author":"Walter","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.cca.2023.117592_b0585","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0590","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3899\/jrheum.100302","article-title":"Use of highly sensitive C-reactive protein for followup of Wegener\u2019s granulomatosis","volume":"37","author":"K\u00e4lsch","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0595","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/rheumatology\/keu427","article-title":"Vasculitis Clinical Research Consortium, Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2023.117592_b0600","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1651-2227.1997.tb08944.x","article-title":"Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan","volume":"86","author":"Koyanagi","year":"1997","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.cca.2023.117592_b0605","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00296-019-04375-9","article-title":"A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study","volume":"39","author":"Nandi","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cca.2023.117592_b0610","first-page":"34","article-title":"Procalcitonin and C-reactive Protein Levels as Biomarkers to Determine Gastrointestinal Involvement in Adult Henoch-Sch\u00f6nlein Purpura Patients","volume":"45","author":"Wang","year":"2020","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.cca.2023.117592_b0615","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10067-014-2773-1","article-title":"Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Sch\u00f6nlein purpura in pediatric patients","volume":"35","author":"Teng","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0620","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3389\/fimmu.2019.01135","article-title":"PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases","volume":"10","author":"Ramirez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0625","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-155-7-201110040-00005","article-title":"Pentraxin-3 as a marker of disease activity in Takayasu arteritis","volume":"155","author":"Dagna","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 117","key":"10.1016\/j.cca.2023.117592_b0630","first-page":"109","article-title":"Study on the association of serum pentraxin-3 and lysosomal-associated membrane protein-2 levels with disease activity in Chinese Takayasu\u2019s arteritis patients","volume":"37","author":"Chen","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0635","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s13075-014-0479-z","article-title":"Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis","volume":"16","author":"Tombetti","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2023.117592_b0640","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1253\/circj.CJ-12-0131","article-title":"Diagnosis and assessment of Takayasu arteritis by multiple biomarkers","volume":"77","author":"Ishihara","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.cca.2023.117592_b0645","doi-asserted-by":"crossref","first-page":"e0245612","DOI":"10.1371\/journal.pone.0245612","article-title":"Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: A systematic review and meta-analysis","volume":"16","author":"Wen","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117592_b0650","doi-asserted-by":"crossref","unstructured":"R. Bilici Salman, G. Koca, S. G\u00fclbahar Ate\u015f, D. Yapar, H. Babaoglu, H. Sat\u0131\u015f, A. Avanoglu G\u00fcler, H. Karadeniz, N. Ata\u015f, H. K\u00fc\u00e7\u00fck, \u00dc.\u00d6. Akdemir, \u015e. Haznedaro\u011flu, A. Tufan, B. G\u00f6ker, H. Pa\u015fao\u011flu, L.\u00d6. Atay, M.A. \u00d6zt\u00fcrk, Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography, Mod Rheumatol. 32 (2022) 938\u2013945. https:\/\/doi.org\/10.1093\/mr\/roab074.","DOI":"10.1093\/mr\/roab074"},{"key":"10.1016\/j.cca.2023.117592_b0655","first-page":"S73","article-title":"Plasma pentraxin-3 levels in patients with Takayasu\u2019s arteritis during routine follow-up","volume":"34","author":"Alibaz-Oner","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0660","doi-asserted-by":"crossref","unstructured":"M. Baldini, N. Maugeri, G.A. Ramirez, C. Giacomassi, A. Castiglioni, S. Prieto-Gonz\u00e1lez, M. Corbera-Bellalta, G. Di Comite, I. Papa, G. Dell\u2019antonio, E. Ammirati, I. Cuccovillo, V. Vecchio, A. Mantovani, P. Rovere-Querini, M.G. Sabbadini, M.C. Cid, A.A. Manfredi, Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia, Arthritis Rheum. 64 (2012) 854\u2013865. https:\/\/doi.org\/10.1002\/art.33411.","DOI":"10.1002\/art.33411"},{"key":"10.1016\/j.cca.2023.117592_b0665","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/1756-185X.14111","article-title":"Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis","volume":"24","author":"Sammel","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cca.2023.117592_b0670","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0675","doi-asserted-by":"crossref","first-page":"e0147091","DOI":"10.1371\/journal.pone.0147091","article-title":"Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis","volume":"11","author":"Simon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117592_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102725","article-title":"IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis","volume":"124","author":"Padoan","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2023.117592_b0685","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00109-020-01955-2","article-title":"Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV)","volume":"98","author":"Manojlovic","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.cca.2023.117592_b0690","doi-asserted-by":"crossref","unstructured":"A. Jonasdottir, A. Antovic, A. Qureshi, A. Nordin, V. Malmstr\u00f6m, I. Gunnarsson, A. Bruchfeld, Pentraxin-3 \u2013 a potential biomarker in ANCA-associated vasculitis, Scandinavian Journal of Rheumatology. (2022) 1\u20139. https:\/\/doi.org\/10.1080\/03009742.2022.2045790.","DOI":"10.1080\/03009742.2022.2045790"},{"key":"10.1016\/j.cca.2023.117592_b0695","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2020.00295","article-title":"Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease","volume":"8","author":"Ching","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.cca.2023.117592_b0700","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624802","article-title":"Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease","volume":"12","author":"Kitoh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0705","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00431-013-2150-0","article-title":"Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"173","author":"Ge","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cca.2023.117592_b0710","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00467-014-3026-x","article-title":"Could serum pentraxin 3 levels and IgM deposition in skin biopsies predict subsequent renal involvement in children with Henoch-Sch\u00f6nlein purpura?","volume":"30","author":"Y\u00fcksel","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cca.2023.117592_b0715","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/art.21669","article-title":"Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis","volume":"54","author":"Van Rossum","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0720","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-022-00827-y","article-title":"Global epidemiology of rheumatoid arthritis","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0725","first-page":"1095","article-title":"High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis","volume":"31","author":"Dessein","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0730","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.12659\/MSM.896562","article-title":"Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis","volume":"22","author":"Zhang","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.cca.2023.117592_b0735","first-page":"419","article-title":"Elevated levels of neopterin and pentraxin 3 in patients with rheumatoid arthritis, Horm Mol Biol","volume":"42","author":"Ekin","year":"2021","journal-title":"Clin. Investig."},{"key":"10.1016\/j.cca.2023.117592_b0740","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2174\/1381612828666220614155037","article-title":"Increased Circulating Pentraxin 3 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis","volume":"28","author":"Guan","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2023.117592_b0745","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686795","article-title":"Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response","volume":"12","author":"Boutet","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110628","article-title":"Pentraxin 3 inhibits fibroblast growth factor 2 induced osteoclastogenesis in rheumatoid arthritis","volume":"131","author":"Zhao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2023.117592_b0755","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2000.01110.x","article-title":"Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)","volume":"119","author":"Luchetti","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0760","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14397595.2019.1681583","article-title":"Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study","volume":"30","author":"Asanuma","year":"2020","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0765","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5114\/aoms.2017.69726","article-title":"Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis?","volume":"16","author":"Balbaloglu","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cca.2023.117592_b0770","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/03009742.2016.1244288","article-title":"Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies","volume":"46","author":"Weitoft","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0775","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/annrheumdis-2020-218460","article-title":"Novel autoantibodies identified in ACPA-negative rheumatoid arthritis","volume":"80","author":"Li","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2023.117592_b0780","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.168.1.450","article-title":"Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats","volume":"168","author":"Yamashita","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102336","article-title":"Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis","volume":"106","author":"Wu","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2023.117592_b0790","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.4049\/jimmunol.1800016","article-title":"IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level ROR\u03b3t Expression","volume":"201","author":"Li","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0795","doi-asserted-by":"crossref","first-page":"e14986","DOI":"10.1016\/j.heliyon.2023.e14986","article-title":"Exosomes derived from synovial fibroblasts from patients with rheumatoid arthritis promote macrophage migration that can be suppressed by miR-124-3p","volume":"9","author":"Nakamachi","year":"2023","journal-title":"Heliyon."},{"key":"10.1016\/j.cca.2023.117592_b0800","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cca.2023.117592_b0805","doi-asserted-by":"crossref","first-page":"538","DOI":"10.20452\/pamw.2963","article-title":"Clinical picture of late-onset systemic lupus erythematosus in a group of Polish patients","volume":"125","author":"Jeleniewicz","year":"2015","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.cca.2023.117592_b0810","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0961203305lu2157oa","article-title":"High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk","volume":"14","author":"Barnes","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.cca.2023.117592_b0815","doi-asserted-by":"crossref","first-page":"19913","DOI":"10.1038\/s41598-020-76789-6","article-title":"Differential parameters between activity flare and acute infection in pediatric patients with systemic lupus erythematosus","volume":"10","author":"Luo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2023.117592_b0820","first-page":"815","article-title":"Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis","volume":"20","author":"Gabay","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0825","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clim.2005.11.006","article-title":"Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6","volume":"119","author":"Suh","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0830","first-page":"454","article-title":"Studies of serum C-reactive protein in systemic lupus erythematosus","volume":"32","author":"Williams","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0835","first-page":"191","article-title":"Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus","volume":"19","author":"Suh","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0840","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.imlet.2017.03.008","article-title":"Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode?","volume":"185","author":"Wang","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cca.2023.117592_b0845","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/CIRCGENETICS.114.000714","article-title":"In Silico Post Genome-Wide Association Studies Analysis of C-Reactive Protein Loci Suggests an Important Role for Interferons","volume":"8","author":"Vaez","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.cca.2023.117592_b0850","article-title":"C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205","volume":"11","author":"Enocsson","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0855","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/clin.1994.1005","article-title":"Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive protein","volume":"70","author":"Du Clos","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cca.2023.117592_b0860","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.11026","article-title":"Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene","volume":"48","author":"Szalai","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0865","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.reuma.2018.07.008","article-title":"Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis","volume":"16","author":"Soliman","year":"2020","journal-title":"Reumatol Clin (engl Ed)."},{"key":"10.1016\/j.cca.2023.117592_b0870","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1021\/bi0607453","article-title":"Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation","volume":"45","author":"Inforzato","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2023.117592_b0875","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13075-018-1666-0","article-title":"Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations","volume":"20","author":"Reynolds","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2023.117592_b0880","first-page":"81","article-title":"Serum Levels of Pentraxin3 and Interlukin36\u25a1 in Patients with Systemic Lupus and their Relation to Disease Activity","volume":"25","author":"Ismail","year":"2018","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0885","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0004563215578190","article-title":"Sucrose non-fermenting AMPK related kinase\/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients","volume":"53","author":"Zineldeen","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2023.117592_b0890","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/08916934.2014.983264","article-title":"Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus","volume":"48","author":"Cie\u015blik","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cca.2023.117592_b0895","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cei.12957","article-title":"Interferon-\u03b1 coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro","volume":"189","author":"Wirestam","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0900","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/14397595.2013.852837","article-title":"Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus","volume":"24","author":"Shimada","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0905","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2019.00029","article-title":"Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis","volume":"10","author":"Gatto","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0910","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/acr.20094","article-title":"Feiring Heart Biopsy Study Group, Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease","volume":"62","author":"Hollan","year":"2010","journal-title":"Arthritis Care Res (hoboken)."},{"key":"10.1016\/j.cca.2023.117592_b0915","doi-asserted-by":"crossref","first-page":"e2520","DOI":"10.1097\/MD.0000000000002520","article-title":"Pentraxin 3 Is Closely Associated With Tubulointerstitial Injury in Lupus Nephritis: A Large Multicenter Cross-Sectional Study","volume":"95","author":"Pang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2023.117592_b0920","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.170.3.1466","article-title":"The Long Pentraxin Ptx3 Is Synthesized in IgA Glomerulonephritis and Activates Mesangial Cells","volume":"170","author":"Bussolati","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0925","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12016-015-8476-9","article-title":"PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis","volume":"49","author":"Bassi","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cca.2023.117592_b0930","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1523-1755.2005.67111.x","article-title":"Human renal epithelial cells produce the long pentraxin PTX3","volume":"67","author":"Nauta","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2023.117592_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102443","article-title":"Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings","volume":"111","author":"Gatto","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2023.117592_b0940","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/art.23626","article-title":"Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus","volume":"58","author":"van Bavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0945","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fimmu.2019.01104","article-title":"The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be","volume":"10","author":"Rekvig","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0950","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/ken507","article-title":"Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus","volume":"48","author":"Augusto","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2023.117592_b0955","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","article-title":"IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus","volume":"69","author":"Bassi","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2023.117592_b0960","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/0886022X.2017.1308258","article-title":"Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study","volume":"39","author":"Yuan","year":"2017","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cca.2023.117592_b0965","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaut.2016.07.002","article-title":"Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB\/NZW F1 mice","volume":"74","author":"Gatto","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2023.117592_b0970","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3389\/fimmu.2018.02081","article-title":"SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype","volume":"9","author":"Gatto","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0975","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10875-005-7828-2","article-title":"Protective molecules\u2013C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity","volume":"25","author":"Kravitz","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b0980","first-page":"814","article-title":"Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients","volume":"26","author":"Keenan","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2023.117592_b0985","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2008.03.006","article-title":"The long pentraxin 3 and its role in autoimmunity","volume":"39","author":"Ortega-Hernandez","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b0990","doi-asserted-by":"crossref","first-page":"e0169830","DOI":"10.1371\/journal.pone.0169830","article-title":"Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"12","author":"Deyab","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117592_b0995","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0161-5890(01)00042-6","article-title":"Human C-reactive protein: expression, structure, and function","volume":"38","author":"Volanakis","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b1000","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/jcm9062004","article-title":"Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development","volume":"9","author":"Dhuri","year":"2020","journal-title":"JCM."},{"key":"10.1016\/j.cca.2023.117592_b1005","doi-asserted-by":"crossref","unstructured":"M.B. Pepys, G.M. Hirschfield, G.A. Tennent, J. Ruth Gallimore, M.C. Kahan, V. Bellotti, P.N. Hawkins, R.M. Myers, M.D. Smith, A. Polara, A.J.A. Cobb, S.V. Ley, J. Andrew Aquilina, C.V. Robinson, I. Sharif, G.A. Gray, C.A. Sabin, M.C. Jenvey, S.E. Kolstoe, D. Thompson, S.P. Wood, Targeting C-reactive protein for the treatment of cardiovascular disease, Nature. 440 (2006) 1217\u20131221. https:\/\/doi.org\/10.1038\/nature04672.","DOI":"10.1038\/nature04672"},{"key":"10.1016\/j.cca.2023.117592_b1010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/cvr\/cvs237","article-title":"Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction","volume":"96","author":"Habersberger","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2023.117592_b1015","doi-asserted-by":"crossref","unstructured":"J. Zeller, K.S. Cheung Tung Shing, T.L. Nero, J.D. McFadyen, G. Krippner, B. Bogner, S. Kreuzaler, J. Kiefer, V.K. Horner, D. Braig, H. Danish, S. Baratchi, M. Fricke, X. Wang, M.G. Kather, B. Kammerer, K.J. Woollard, P. Sharma, C.J. Morton, G. Pietersz, M.W. Parker, K. Peter, S.U. Eisenhardt, A novel phosphocholine\u2010mimetic inhibits a pro\u2010inflammatory conformational change in C\u2010reactive protein, EMBO Mol Med. 15 (2023) e16236. https:\/\/doi.org\/10.15252\/emmm.202216236.","DOI":"10.15252\/emmm.202216236"},{"key":"10.1016\/j.cca.2023.117592_b1020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","article-title":"C-reactive protein and implications in rheumatoid arthritis and associated comorbidities","volume":"51","author":"Pope","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.cca.2023.117592_b1025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.phrs.2015.07.005","article-title":"Where are we heading to in pharmacological IBD therapy?","volume":"100","author":"Rogler","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cca.2023.117592_b1030","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s10753-015-0151-z","article-title":"Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation","volume":"38","author":"Sun","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.cca.2023.117592_b1035","doi-asserted-by":"crossref","first-page":"29983","DOI":"10.1074\/jbc.M805631200","article-title":"Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells","volume":"283","author":"Doni","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2023.117592_b1040","doi-asserted-by":"crossref","first-page":"e0220772","DOI":"10.1371\/journal.pone.0220772","article-title":"Glucocorticoids regulate pentraxin-3 expression in human airway smooth muscle cells","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2023.117592_b1045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2015.04.106","article-title":"Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?","volume":"190","author":"Lidani","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2023.117592_b1050","doi-asserted-by":"crossref","unstructured":"G.D. Norata, P. Marchesi, V.K. Pulakazhi Venu, F. Pasqualini, A. Anselmo, F. Moalli, I. Pizzitola, C. Garlanda, A. Mantovani, A.L. Catapano, Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis, Circulation. 120 (2009) 699\u2013708. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.806547.","DOI":"10.1161\/CIRCULATIONAHA.108.806547"},{"key":"10.1016\/j.cca.2023.117592_b1055","doi-asserted-by":"crossref","unstructured":"Y. Liu, H. Wang, X. Zhou, N. Li, Y. Guo, T. Chen, Pentraxin 3 promotes the osteoblastic differentiation of MC3T3-E1 cells through the PI3K\/Akt signaling pathway, Bioscience Reports. 40 (2020) BSR20201165. https:\/\/doi.org\/10.1042\/BSR20201165.","DOI":"10.1042\/BSR20201165"},{"key":"10.1016\/j.cca.2023.117592_b1060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood-2003-10-3433","article-title":"Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis","volume":"104","author":"Rusnati","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117592_b1065","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.ATV.0000177807.54959.7d","article-title":"Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo","volume":"25","author":"Camozzi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2023.117592_b1070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coi.2008.05.004","article-title":"Pentraxins, humoral innate immunity and tissue injury","volume":"20","author":"Manfredi","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cca.2023.117592_b1075","first-page":"1182","article-title":"Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation","volume":"2016","author":"Bonacina","year":"1862","journal-title":"BBA"},{"key":"10.1016\/j.cca.2023.117592_b1080","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.ATV.0000012282.39306.64","article-title":"Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation","volume":"22","author":"Napoleone","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2023.117592_b1085","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1038\/emm.2015.37","article-title":"Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK\/I\u03baB\/NF-\u03baB, in atherosclerotic cell model","volume":"47","author":"Qiu","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cca.2023.117592_b1090","doi-asserted-by":"crossref","first-page":"9893682","DOI":"10.1155\/2019\/9893682","article-title":"Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose","volume":"2019","author":"Zhou","year":"2019","journal-title":"Mediators Inflamm."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:07:05Z","timestamp":1762114025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123003947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":218,"alternative-id":["S0009898123003947"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117592","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pentraxin family in autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117592"}}